Skip to content

Effectiveness and safety of Formulation HB01 for instant relief from heartburn.

A double-blind randomized placebo controlled Clinical study to evaluate the effectiveness and safety of Formulation HB01 for instant relief from heartburn. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058553
Enrollment
120
Registered
2023-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

Nutrin GmbH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Gender: Non-pregnant, non-lactating female aged between 18 to 65. 2.Subject willing to give written informed consent 3.Women of child bearing potential must have a negative urine pregnancy test. 4.Free of any Kidney and Heart disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE.

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant, breast feeding, or planning to become pregnant during the study. 2.Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 3.Have participated in any interventional clinical trial in the previous 30 days. 4.Have a known sensitivity to sorbitol and any of the constituents of the test product. 5.Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years. 6.Patients with Cholecystectomy. 7.Subject with an elevated level of calcium.

Design outcomes

Primary

MeasureTime frame
Change in SGA self-evaluation score Change in RDQ scoreTimepoint: Time frame 0-1 day Time frame 0-1 day

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactPuneet Mittal

Mittal Global Clinical Trial Services

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026